Plasma cell inflammation
|
disease |
|
Disease or Syndrome
|
16
|
|
0.010 |
None |
1.000 |
1 |
|
2002 |
2002 |
Aggressive Adult Non-Hodgkin Lymphoma
|
disease |
|
Neoplastic Process
|
16
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Leishmania donovani disease
|
disease |
|
Disease or Syndrome
|
16
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Trisomy 4
|
disease |
Pathological Conditions, Signs and Symptoms
|
Disease or Syndrome
|
16
|
|
0.010 |
None |
1.000 |
1 |
|
2003 |
2003 |
Primary immunoglobulin A nephropathy (disorder)
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases; Immune System Diseases
|
Disease or Syndrome
|
16
|
1
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Refractory Leukemia
|
disease |
Neoplasms
|
Neoplastic Process
|
17
|
|
0.020 |
None |
1.000 |
2 |
|
2019 |
2019 |
Central nervous system leukaemia
|
disease |
Neoplasms
|
Neoplastic Process
|
17
|
1
|
0.010 |
None |
< 0.001 |
1 |
|
2019 |
2019 |
Impaired T cell function
|
phenotype |
|
Cell or Molecular Dysfunction
|
18
|
|
0.100 |
None |
|
0 |
|
|
|
Multiple sclerosis relapse
|
disease |
|
Disease or Syndrome
|
19
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
B-cell lymphoma refractory
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
21
|
|
0.050 |
None |
1.000 |
5 |
|
2019 |
2019 |
Hyperleukocytosis
|
disease |
|
Disease or Syndrome
|
21
|
|
0.020 |
None |
1.000 |
2 |
|
1995 |
2015 |
Nonketotic Hyperglycinemia
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Nervous System Diseases
|
Disease or Syndrome
|
21
|
182
|
0.010 |
None |
1.000 |
1 |
|
1991 |
1991 |
Refractory Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
22
|
|
0.020 |
None |
1.000 |
2 |
|
2014 |
2018 |
Post-transplant lymphoproliferative disorder
|
disease |
Infections; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
22
|
2
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Liquid Tumor
|
disease |
|
Neoplastic Process
|
22
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Extranodal marginal zone B-cell lymphoma
|
disease |
|
Neoplastic Process
|
23
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Double-Hit Lymphoma
|
disease |
|
Neoplastic Process
|
24
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Precursor B-lymphoblastic lymphoma/leukemia
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
25
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Infant Leukemia
|
disease |
|
Neoplastic Process
|
27
|
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Cytokine Release Syndrome
|
disease |
Pathological Conditions, Signs and Symptoms; Chemically-Induced Disorders
|
Disease or Syndrome
|
29
|
|
0.100 |
None |
0.920 |
25 |
|
2016 |
2020 |
Diffuse large B-cell lymphoma refractory
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
29
|
|
0.100 |
None |
1.000 |
10 |
|
2018 |
2020 |
Humoral immune defect
|
group |
Immune System Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
29
|
|
0.020 |
None |
0.500 |
2 |
|
2012 |
2013 |
Recurrent bronchitis
|
disease |
Infections; Respiratory Tract Diseases
|
Disease or Syndrome
|
29
|
1
|
0.100 |
None |
|
0 |
|
|
|
Ph-Like Acute Lymphoblastic Leukemia
|
disease |
|
Neoplastic Process
|
30
|
1
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
TUBEROUS SCLEROSIS 1 (disorder)
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Nervous System Diseases
|
Disease or Syndrome
|
32
|
128
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |